Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane Impacts Survival of HER2-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Anticancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: The JONIE1 Study
Anticancer Res. 2021 Feb 01;41(2)1063-1068, A Yamada, K Nakazawa, K Akazawa, K Narui, I Endo, Y Hasegawa, N Kohno, T IshikawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.